Format

Send to

Choose Destination
J Gen Intern Med. 2014 Feb;29(2):388-94. doi: 10.1007/s11606-013-2595-x. Epub 2013 Sep 4.

Pitfalls in hemoglobin A1c measurement: when results may be misleading.

Author information

1
Division of Endocrinology, Diabetes, and Metabolism, Winthrop-University Hospital, Mineola, NY, USA, mradin@winthrop.org.

Abstract

Since the beginning of clinical use in the 1970s, hemoglobin A1c (A1c) has become the standard tool for monitoring glycemic control in patients with diabetes. The role of the A1c test was broadened in 2010, when the American Diabetes Association added A1c as a diagnostic criterion for diabetes. Because of hemoglobin A1c's integral role in diagnosis and treatment, it is important to recognize clinical scenarios and interfering factors that yield false results. The purpose of this review is to describe the A1c measurement, outline clinical scenarios or factors that may yield false results, and describe alternative laboratory biomarkers.

PMID:
24002631
PMCID:
PMC3912281
DOI:
10.1007/s11606-013-2595-x
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Springer Icon for PubMed Central
Loading ...
Support Center